Riskpilot← Back to searchSign inGet full accessAMPLEXA GENETICS A/S
A/SActiveCVR 29428441Sverigesgade 24Engineering activities and related technical consultancy · NACE 7112Est. 200612 employees
Revenue 2024
DKK 3,4M
+5% vs 2023
EBITDA margin
-220.2%
-119% vs 2023
Equity ratio
-239.4%
Financial strength
Net profit 2024
DKK -11,1M
-255% vs 2023
| Revenue | DKK 3,4M | +5% |
| EBITDA | DKK -7,5M | -119% |
| Net profit | DKK -11,1M | -255% |
| Total assets | DKK 3,6M | -76% |
| Equity | DKK -8,7M | -467% |
| Employees | 12 | — |
Legal name
AMPLEXA GENETICS A/S
CVR number
29428441
Legal form
Aktieselskab
NACE code
7112 · Engineering activities and related technical consultancy
Founded
25. marts 2006
Share capital
DKK 20.600.000
Employees
12 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør sammen med et medlem af bestyrelsen eller af bestyrelsen i forening.
Company purpose
Selskabets formål er at arbejde med virksomhed indenfor genetisk screening, dna-undersøgelser samt hermed beslægtet virksomhed
Address
Sverigesgade 24
Phone
+4566116628
Email
info@amplexa.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -538 | -786 | -186 | 157 | 440 | 718 | 907 | 2.831 | 12.424 | 20.278 | 5.495 | 3.225 | 3.399 |
| Staff expenses | -1.287 | -1.650 | -2.905 | -2.995 | -3.018 | -3.343 | -4.065 | -3.763 | -5.336 | -9.031 | -7.228 | -6.639 | -6.405 |
| EBITDA | -1.825 | -2.436 | -3.091 | -2.838 | -2.578 | -2.624 | -3.158 | -932 | 7.088 | 11.247 | -1.733 | -3.414 | -7.483 |
| Depreciation & amort. | -829 | -559 | -579 | -568 | -283 | -207 | -326 | -375 | -630 | -810 | -818 | -649 | -480 |
| EBIT | -2.654 | -2.995 | -3.670 | -3.406 | -2.861 | -2.832 | -3.484 | -1.307 | 6.458 | 10.437 | -2.551 | -4.063 | -7.963 |
| Net financials | -89 | -76 | -61 | -174 | -42 | -375 | -483 | -545 | -585 | -495 | -474 | 17 | -31 |
| Profit before tax | -2.743 | -3.071 | -3.731 | -3.579 | -2.903 | -3.207 | -3.967 | -1.852 | 5.873 | 9.943 | -3.025 | -4.046 | -7.994 |
| Tax | -673 | 2.790 | -344 | -206 | -207 | -238 | -306 | -352 | -0 | -2.386 | -742 | -915 | 3.115 |
| Net profit | -2.070 | -5.861 | -3.387 | -3.374 | -2.696 | -2.969 | -3.661 | -1.501 | 5.873 | 12.328 | -2.282 | -3.131 | -11.108 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 5.412 | 4.473 | 3.037 | 2.309 | 2.705 | 6.331 | 5.257 | 3.952 | 12.291 | 18.363 | 12.284 | 14.976 | 3.647 |
| Equity | -6.961 | -12.822 | -16.209 | -19.582 | -22.278 | -25.248 | -28.909 | -30.410 | -24.537 | -12.208 | -14.491 | 2.378 | -8.730 |
| Long-term debt | 11.265 | 16.165 | 17.665 | 19.965 | 23.400 | 29.279 | 31.989 | 33.430 | 33.001 | 26.260 | 25.610 | 10.610 | 10.610 |
| Short-term debt | 1.108 | 1.130 | 1.580 | 1.926 | 1.583 | 2.300 | 2.177 | 932 | 3.827 | 4.311 | 1.165 | 1.987 | 1.767 |
| Total debt | 12.373 | 17.295 | 19.245 | 21.891 | 24.983 | 31.579 | 34.166 | 34.362 | 36.828 | 30.571 | 26.775 | 12.597 | 12.377 |
EBITDA margin
-220.2%
This company
15.8%
Market median
-1494% vs market
20122024
Equity ratio
-239.4%
This company
38.2%
Market median
-727% vs market
20122024
Return on equity
-1110834400.0%
This company
18.4%
Market median
-6037143578% vs market
20122024
Net profit margin
-326.8%
This company
8.1%
Market median
-4135% vs market
20122024
Asset turnover
0.93×
This company
1.12×
Market median
+17% vs market
20122024
Debt / equity
1.42×
This company
0.62×
Market median
-129% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KB Management | Management | 2006 | — | — |
PC Founder | Founder | 2006 | — | — |
HA Chief Executive Officer | Chief Executive Officer | 2011 | — | — |
HH Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2011 | — | — | |
| Chairman | 2026 | — | — | |
| Board of Directors | 2013 | — | — | |
| Board of Directors | 2018 | — | — | |
| Chairman | 2015 | — | — | |
| Board of Directors | 2013 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2008 | — | — | |
| Chairman | 2013 | — | — | |
| Board of Directors | 2009 | — | — | |
| Board of Directors | 2006 | — | — | |
| Board of Directors | 2006 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 33.3% | 33.3% | 2024 | |
SCIENT. INVEST ApS | Company | 33.3% | 33.3% | 2024 |
| Individual | 25.0% | 25.0% | 2023 | |
| Individual | 20.0% | 20.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AMPLEXA GENETICS A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Klaus Brusgaard | Management | 0 companies |
| P&F CONSECO | Founder | 0 companies |
| Hans Atli Eli Albinus Dahl | Chief Executive Officer | 0 companies |
| Helle Hjalgrim | Chief Executive Officer | 0 companies |
| Eydfinn Reydberg | Board of Directors | 0 companies |
| Magnus Herdalur | Chairman | 0 companies |
| Leif Mosekilde | Board of Directors | 0 companies |
| Charles Steven Glavas | Board of Directors | 0 companies |
| Johan Jan Albinus Dahl | Chairman | 0 companies |
| Nils Christian Jensen | Board of Directors | 0 companies |
| Ulf Bech Christensen | Board of Directors | 0 companies |
| Leif Abrahamsen | Board of Directors | 0 companies |
| Andras Splidt | Board of Directors | 0 companies |
| Jørn Kildegaard Andersen | Chairman | 0 companies |
| Pál Magni Weihe | Board of Directors | 0 companies |
| Marita Rasmussen | Board of Directors | 0 companies |
| Johan Dahl | Board of Directors | 0 companies |